CAS 1191450-19-7

Burixafor hydrobromide

CAS : 1191450-19-7

Burixafor hydrobromide is an anti-tumor agent that belongs to the class of antagonists. It is a potent and selective antagonist of the erythropoietin receptor (EPOR). This drug has been shown to have systemic activity in cancer models by inhibiting tumor growth. Burixafor hydrobromide inhibits tumor cell proliferation by blocking EPOR signaling, which is important for normal red blood cell production. This agent also has a high affinity for deuterated compounds and may be used as a tracer or radiotracer for imaging tumors.

Formule : C₂₇H₆₀Br₃N₈O₆P

Degré de pureté : Min. 95%

Masse moléculaire : 863.5 g/mol

Ref: 3D-RXB45019

Burixafor hydrobromide

CAS : 1191450-19-7

Burixafor hydrobromide is an oral CXCR4 blocker with anti-angiogenic properties, potentially treating choroid neovascularization.

Formule : C₂₇H₅₂BrN₈O₃P

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 647.644

Ref: TM-T10635